CHANTIX Drug Patent Profile

✉ Email this page to a colleague

When do Chantix patents expire, and what generic alternatives are available?

Chantix is a drug marketed by Pf Prism Cv and is included in one NDA.

The generic ingredient in CHANTIX is varenicline tartrate. There are twelve drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Chantix

A generic version of CHANTIX was approved as varenicline tartrate by ENDO OPERATIONS on August 11^th, 2021.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CHANTIX?
What are the global sales for CHANTIX?
What is Average Wholesale Price for CHANTIX?

Summary for CHANTIX

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	98
Clinical Trials:	167
Patent Applications:	132
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CHANTIX
Drug Sales Revenues:	Drug sales revenues for CHANTIX
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CHANTIX
What excipients (inactive ingredients) are in CHANTIX?	CHANTIX excipients list
DailyMed Link:	CHANTIX at DailyMed

Drug patent expirations by year for CHANTIX

Recent Clinical Trials for CHANTIX

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Massachusetts General Hospital	Phase 3
Mayo Clinic	Early Phase 1
Duke University	Phase 4

See all CHANTIX clinical trials

Pharmacology for CHANTIX

Drug Class	Cholinergic Receptor Agonist Partial Cholinergic Nicotinic Agonist
Mechanism of Action	Cholinergic Agonists Partial Cholinergic Nicotinic Agonists

Paragraph IV (Patent) Challenges for CHANTIX

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
CHANTIX	Tablets	varenicline tartrate	0.5 mg and 1 mg	021928	5	2010-05-10

US Patents and Regulatory Information for CHANTIX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pf Prism Cv	CHANTIX	varenicline tartrate	TABLET;ORAL	021928-001	May 10, 2006		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pf Prism Cv	CHANTIX	varenicline tartrate	TABLET;ORAL	021928-002	May 10, 2006		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for CHANTIX

See the table below for patents covering CHANTIX around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
African Intellectual Property Organization (OAPI)	12181	Aryl fused azapolycyclic compounds.	⤷ Sign Up
Eurasian Patent Organization	005316	АРИЛКОНДЕНСИРОВАННЫЕ АЗАПОЛИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ (ARYL FUSED AZAPOLYCYCLIC COMPOUNDS)	⤷ Sign Up
African Regional IP Organization (ARIPO)	1860	Aryl fused azapolycyclic compounds.	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for CHANTIX

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1044189	91442	Luxembourg	⤷ Sign Up	91442, EXPIRES: 20210926
1044189	122008000038	Germany	⤷ Sign Up	PRODUCT NAME: VARENICLIN GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES UNTER EINSCHLUSS VON TARTRAT; REGISTRATION NO/DATE: EU/1/06/360/001-010 20060926
1044189	C01044189/01	Switzerland	⤷ Sign Up	PRODUCT NAME: VARENICLIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 57736 21.12.2006
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description